Clinical Trial Update: Circulating Tumor DNA [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates a study evaluating circulating tumor DNA in estrogen receptor-positive breast cancer is currently recruiting at Yale U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: Yale University | Conditions: ER+ Breast Cancer | Phase 2 | Status: RECRUITING